Cite
HARVARD Citation
Fernández-Nogueira, P. et al. (2018). Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer. Cancer letters. pp. 70-83. [Online].